← Insider buys
ROIV

Roivant Sciences Ltd. · Healthcare

Chief Accounting Officer Rakhi Kumar sold $1.2M of Roivant Sciences Ltd.

Sold$1,210,083
$12.18Price
99,350Shares
−33%Stake

What ROIV did after the filing

Filed Sep 12Copier in Sep 13
The stock from Wed, Sep 13 open, $11.11
−23.1%
S&P 500, same days
−6.1%

Measured over 30 trading days, to the Oct 25 close.

Traded Fri, Sep 8. Filed Tue, Sep 12, 5:30 PM ET, after the close. Returns use the Sep 13 open and the Oct 25 close. Not investment advice.